Results · Apr-Jun 2026
Viyash Scientific Q1 FY27 results
BlockbusterBlockbuster: sales up 20% or more & profit up 30% or more on the same quarter last year, with a wider operating margin.
Sales grew 114% to ₹946 crore from ₹441 crore in Apr-Jun 2025.
Operating profit grew 242% to ₹178 crore, an operating margin of 18.8% (up 7.0 points from a year ago).
Net profit grew 351% to ₹79.3 crore from ₹17.6 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +3%, net profit +19%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 946.4 | 441.4 | +114% |
| Operating profit (EBITDA) | 178.4 | 52.2 | +242% |
| Operating margin | 18.8% | 11.8% | +7.0 pts |
| Net profit | 79.3 | 17.6 | +351% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.